The ongoing research into the long-term effects of cagrilintide and tirzepatide is crucial, as it will help determine their place in the broader landscape of diabetes and obesity management
The best choice depends on your individual health goals and preferences
In terms of weight loss outcomes, the TRIUMPH-1 trial suggests that Retatrutide may provide superior results, with up to a 28.3% weight loss over 80 weeks compared to tirzepatide's 20.9% achieved in other studies
Mochi Health offers a comprehensive obesity medicine program tailored to your unique needs, including one-on-one support from licensed physicians and 24/7 customer support
Report warning signs immediately: unilateral leg swelling or pain, chest discomfort, unexplained shortness of breath, or calf tenderness
Patients should also confirm whether the platform's clinicians have access to prior labs (particularly HbA1c, TSH, and a lipid panel) before initiating therapy